Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
Accessing GP Services: A Detailed Overview
August 31, 2023
Unvalidated Laboratory Testing
August 2, 2023
Osteoporosis (Thinning bones)
August 1, 2023
Understanding a Fever
July 31, 2023
Living with & Managing Chronic Illness
July 27, 2023
Understanding Your Blood Test Results
May 23, 2023
Charity Walk Update: Nearing the Finish Line
April 28, 2023
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video